Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6551
Meridian
MRBK
$221M
| – | – |
-156
| Closed | -$1K | – |
|
|
BINI
6552
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | -$33K |
2016 Q2
9 quarters
|
|
|
FEED
6553
DELISTED
ENVUE MEDICAL INC NEW
FEED
| – | – |
0
| – | – |
2018 Q2
1 quarter
|
|
6554
Neonode
NEON
$12.9M
| – | – |
0
| – | – |
2018 Q2
1 quarter
|
|
6555
Virtus Newfleet Multi-Sector Bond ETF
NFLT
$513M
| – | – |
-2,183
| Closed | -$53K | – |
|
6556
InspireMD
NSPR
$21.3M
| $0 | ﹤0.01% |
1
| – | – |
2018 Q1
2 quarters
|
|
6557
XMAX Inc
XMAX
$525M
| $0 | ﹤0.01% |
+2
| New | +$88 |
2018 Q3
0 quarters
|
|
6558
Oragenics
OGEN
$1.96M
| – | – |
-43
| Closed | -$107K | – |
|
6559
OptimumBank Holdings
OPHC
$111M
| $0 | ﹤0.01% |
26
+6
| +30% | +$31 |
2018 Q2
1 quarter
|
|
6560
Organogenesis Holdings
ORGO
$129M
| $0 | ﹤0.01% |
2
| – | – |
2017 Q4
3 quarters
|
|
6561
TDH Holdings
PETZ
$12.9M
| – | – |
-6
| Closed | -$1K | – |
|
6562
Planet Green Holdings
PLAG
$9.34M
| $0 | ﹤0.01% |
4
| – | – |
2015 Q3
12 quarters
|
|
6563
Protalix BioTherapeutics
PLX
$211M
| $0 | ﹤0.01% |
38
-2,950
| -99% | -$14.8K |
2013 Q4
19 quarters
|
|
6564
Polar Power
POLA
$3.6M
| $0 | ﹤0.01% |
+13
| New | +$550 |
2018 Q3
0 quarters
|
|
6565
Peraso
PRSO
$5.46M
| – | – |
0
| – | – |
2017 Q4
3 quarters
|
|
6566
PermRock Royalty Trust Unit
PRT
$22.3M
| – | – |
-1,655
| Closed | -$27K | – |
|
6567
Cerenome
CNSY
$12.9M
| – | – |
0
| – | – |
2013 Q2
21 quarters
|
|
6568
Pulmatrix
PULM
$4.97M
| $0 | ﹤0.01% |
2
| – | – |
2017 Q1
6 quarters
|
|
6569
Pyxis Tankers
PXS
$76.8M
| – | – |
-975
| Closed | -$4K | – |
|
6570
Recon Technology
RCON
$20M
| – | – |
0
| – | – |
2018 Q1
2 quarters
|
|
6571
Reading International Class B
RDIB
$263M
| $0 | ﹤0.01% |
1
| – | – |
2017 Q4
3 quarters
|
|
6572
ProShares Short Real Estate
REK
$12M
| – | – |
-15
| Closed | – | – |
|
6573
DELISTED
Regulus Therapeutics
RGLS
| $0 | ﹤0.01% |
15
| – | – |
2013 Q4
19 quarters
|
|
6574
ProShares UltraShort SmallCap600
SDD
$1.66M
| $0 | ﹤0.01% |
1
| – | – |
2017 Q2
5 quarters
|
|
6575
iShares MSCI Global Sustainable Development Goals ETF
SDG
$159M
| – | – |
-200
| Closed | -$11K | – |
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.